AGIO CIK: 1439222

Agios Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.41
FY22:
−0.31
FY23:
−0.30
FY24:
−0.39
FY25:
−0.37
Change from FY21 to FY25
billions USD
FY21:
1.25
FY22:
0.24
FY23:
0.24
FY24:
0.36
FY25:
0.38
Change from FY21 to FY25
billions USD
FY21:
−0.77
FY22:
0.00
FY23:
0.01
FY24:
0.01
FY25:
0.01
billions USD
FY21:
0.08
FY22:
−0.06
FY23:
−0.05
FY24:
−0.01
FY25:
0.01
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.41
FY22:
−0.31
FY23:
−0.30
FY24:
−0.39
FY25:
−0.38

All amounts in billions USD Data source:SEC EDGAR